Cardiovascular

Association of sleep time with all-cause and cardiovascular mortality among individuals with advanced cardiovascular-kidney-metabolic syndrome: A NHANES-based prospective cohort study.

TL;DR

Among 4266 US adults with advanced (Stage 3-4) CKM syndrome, long sleep (>8 hours) was associated with higher cardiovascular mortality and borderline higher all-cause mortality, short sleep was not significantly associated with either outcome, and sleep time showed a U- or J-shaped association with death rates.

Key Findings

Long sleep (>8 hours/night) was significantly associated with higher cardiovascular mortality in adults with advanced CKM syndrome compared with 7-8 hours of sleep.

  • Fully adjusted Cox model: HR 1.53; 95% CI 1.14-2.07; P = .005.
  • Reference group was 7-8 hours of self-reported sleep per night.
  • 465 CVD deaths occurred among 4266 participants during a median 7.6 years of follow-up.

Long sleep was borderline significantly associated with higher all-cause mortality.

  • Fully adjusted Cox model: HR 1.21; 95% CI 1.00-1.46; P = .05.
  • There were 1294 all-cause deaths during follow-up.
  • Mortality was ascertained by linkage to the National Death Index through December 31, 2019.

Short sleep (<7 hours/night) was not significantly associated with all-cause or cardiovascular mortality.

  • The fully adjusted Cox models showed no significant association for short sleep versus the 7-8 hour reference for either outcome.
  • Sleep duration was categorized as <7, 7-8 (reference), and >8 hours.

Restricted cubic spline analysis showed a U-shaped nonlinear association between sleep time and overall mortality.

  • P for nonlinearity = .0017.
  • The authors describe the overall relationship of sleep time with death rates as U-shaped or J-shaped.

The study was a prospective cohort analysis of NHANES 2005-2018 participants with advanced (Stage 3-4) CKM syndrome.

  • 4266 adult participants were included.
  • Sleep time was self-reported.
  • Analyses used Kaplan-Meier curves, multivariable Cox proportional hazards models, and restricted cubic splines.

The authors conclude that sleep time should be considered an important health marker in managing advanced CKM syndrome and that long sleepers need additional clinical assessment.

  • Sleeping more than 8 hours was deemed a pronounced risk indicator for both CVD and overall mortality.
  • This is an observational association, based on self-reported sleep.

What This Means

This study followed 4266 US adults with advanced cardiovascular-kidney-metabolic (CKM) syndrome, a combination of heart, kidney, and metabolic problems. The adults were drawn from a national health survey and followed for a median of about 7.6 years. The researchers asked whether the amount of sleep people reported was linked to their risk of dying from any cause or from cardiovascular disease. People who slept more than 8 hours a night had about a 53% higher risk of cardiovascular death than those who slept 7-8 hours. Their risk of death from any cause was about 21% higher, a result right at the edge of statistical significance. People who slept less than 7 hours did not have a significantly different risk. Overall, the relationship between sleep and death risk was U- or J-shaped, with risk rising at the long-sleep end. This research suggests that sleep duration may be a useful marker of health risk in people with advanced CKM syndrome, and that long sleep may signal a need for closer clinical attention. The study is observational and relies on self-reported sleep, so it cannot show that long sleep causes death. Long sleep may instead reflect underlying illness.

Have a question about this study?

Citation

Xiong Y, Yin Y, Wang J, Lan K, Liang J, Han W. (2026). Association of sleep time with all-cause and cardiovascular mortality among individuals with advanced cardiovascular-kidney-metabolic syndrome: A NHANES-based prospective cohort study.. Medicine. https://doi.org/10.1097/MD.0000000000051259